Gallic Acid

Gallic Acid

SCHEMBL678990

O=C(O)c1cc(O)c(O)c(O)c1.O=C(O)c1cc(O)c(O)c(O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 1.00
CA1 P00915 4/20 1.00
CA2 P00918 4/20 1.00
CA7 P43166 4/20 1.00
CA9 Q16790 4/20 1.00
CA14 Q9ULX7 4/20 1.00
KDM4E B2RXH2 4/20 1.00
MAPT P10636 3/20 1.00
CA4 P22748 3/20 1.00
CA6 P23280 3/20 1.00
LMNA P02545 3/20 1.00
TDP1 Q9NUW8 3/20 1.00
ALDH1A1 P00352 2/20 1.00
FUT7 Q11130 2/20 1.00
CA3 P07451 2/20 1.00
CA5A P35218 2/20 1.00
CA5B Q9Y2D0 2/20 1.00
TP53 P04637 1/20 1.00
SELL P14151 1/20 1.00
HPGD P15428 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gallic Acid SCHEMBL29484566 1.00 CA12 (1.00) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL1845406 1.00 CA12 (1.00) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL15012 1.00 CA12 (1.00) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL30375631 1.00 CA12 (1.00) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL4918056 1.00 CA12 (1.00) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL8088102 1.00 CA12 (1.00) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL9678849 0.97 CA12 (0.94) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL597299 0.97 CA12 (0.94) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL1334688 0.97 CA12 (0.94) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL21273261 0.97 CA12 (0.94) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 554 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3346842-B1 STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME NOVONESIS PLANT BIOSOLUTIONS AS (DK) 2026-03-25 EP claimed
CN-115561366-B Method for simultaneously measuring contents of 16 tea components in instant black tea 陕西理工大学 2025-04-11 CN claimed
CN-119744162-A Polyester film-forming polymers for alcohol-based sunscreen formulations 诺力昂化学品国际有限公司 2025-04-01 CN claimed
CN-119522090-A Polyvinyl alcohol film-forming polymers for alcohol-based sunscreen formulations and methods of use thereof 诺力昂化学品国际有限公司 2025-02-25 CN claimed
US-12163004-B2 Polymer composites WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) 2024-12-10 US claimed
EP-4408480-A1 COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE The Regents Of The University Of Michigan (US) 2024-08-07 EP claimed
US-20240182435-A1 CHEMICAL SYNTHESIS METHOD OF PRODELPHINIDIN B9 GALLATE ZHEJIANG UNIVERSITY (CN) 2024-06-06 US claimed
US-20240108597-A1 GALLOYLATED PROCYANIDINS FOR INCREASING INTRACELLULAR NITRIC OXIDE PRODUCTION UNIVERSITY OF SOUTH FLORIDA (US) 2024-04-04 US claimed
US-11766422-B2 Galloylated procyanidins for treating endovascular dysfunction and increasing blood flow UNIVERSITY OF SOUTH FLORIDA (US) 2023-09-26 US claimed
CN-113015517-B Personal care formulations comprising multistage polymers with carbosiloxanes 陶氏环球技术有限责任公司 2023-06-30 CN claimed
EP-1169304-A1 8-8, 6-6 AND 6-8 CATECHIN AND EPICATECHIN DIMERS AND METHODS FOR THEIR PREPARATION Mars Incorporated (US) 2002-01-09 EP claimed
EP-1129628-A1 POULTRY PRODUCIBILITY IMPROVER AND POULTRY PRODUCIBILITY IMPROVEMENT METHOD Taiyo Kagaku Co., Ltd. (JP) 2001-09-05 EP claimed
EP-0761226-B1 Composition and method of potentiating antibiotics with polyphenols MITSUI NORIN KK (JP) 2001-05-30 EP claimed
US-6156912-A 88, 66, and 68 catechin and epicatechin dimers and methods for their preparation MARS, INCORPORATED (US) 2000-12-05 US claimed
WO-2000061547-A1 8-8, 6-6 AND 6-8 CATECHIN AND EPICATECHIN DIMERS AND METHODS FOR THEIR PREPARATION MARS, INCORPORATED (US) 2000-10-19 WO claimed
EP-1005862-A1 ANTI-CHLAMYDIA AGENTS Mitsui Norin Co., Ltd. (JP) 2000-06-07 EP claimed
CN-1171238-A Method for enhancing anticarcinogenic effect TUMOR INST CHINESE ACADEMY OF (CN) 1998-01-28 CN claimed
EP-0443090-B1 Agent for preventing infection with methicillin-resistant staphylococcus MITSUI NORIN KK (JP) 1996-01-10 EP claimed
EP-0415126-B1 Anti-dental plaque agents MITSUI NORIN KK (JP) 1995-02-01 EP claimed
EP-0417385-B1 Preventive and curative medicament against infection with influenza virus, containing tea or tea polyphenols MITSUI NORIN KK (JP) 1994-07-20 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108597-A1 GALLOYLATED PROCYANIDINS FOR INCREASING INTRACELLULAR NITRIC OXIDE PRODUCTION NOS1, NOS2, TNNC1 CA12 4637/4885CA1 4413/4885CA2 1215/4885
US-11766422-B2 Galloylated procyanidins for treating endovascular dysfunction and increasing blood flow PLAT, F2, F2R CA12 4291/4885CA1 3860/4885CA2 2680/4885
US-20240182435-A1 CHEMICAL SYNTHESIS METHOD OF PRODELPHINIDIN B9 GALLATE C9, GAPVD1, GCLC CA12 2768/4885CA1 3461/4885CA2 2999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.